1. What Is the Cardiac Implantable Electronic Device Market?
The Cardiac Implantable Electronic Device Market covers pacemakers, implantable cardioverter-defibrillators, cardiac resynchronisation therapy devices, and subcutaneous ICD systems for cardiac rhythm management. CIED encompasses single and dual-chamber pacemakers, ICD and CRT-D devices, subcutaneous S-ICD, extravascular ICD, and leadless pacemaker systems. Market dynamics reflect CIED ageing patient population expanding pacemaker indication, leadless pacemaker adoption reducing lead-related complications, and subcutaneous ICD competing with transvenous ICD for primary prevention.
2. Cardiac Implantable Electronic Device Market Size & Forecast
3. Emerging Technologies
- AI CIED remote monitoring platforms detecting arrhythmia trends before symptomatic episodes enable proactive intervention are advancing. Growing cardiac programme and health system adoption is driven by heart failure unplanned hospitalisation reduction requirements embedded in value-based care and CMS quality reporting frameworks.
- Rechargeable CIED batteries reducing generator replacement procedures are advancing as longevity tools. Growing adoption is driven by repeat surgical replacement burden reduction for patients.
- Cardiac pacing algorithm optimisation using machine learning to personalise AV delay and pacing output are advancing. Growing adoption is driven by CRT non-responder rate improvement requirements.
- Communicating CIED platforms enabling device-to-device communication between pacemaker and defibrillator are advancing. Growing electrophysiology programme adoption is driven by the multi-device, multi-patient CIED network management requirements of large implant clinic follow-up operations.
Similar technologies are also transforming adjacent markets. Learn more in our Electrophysiology Lab Market.
4. Key Market Opportunity
The primary growth driver in the Cardiac Implantable Electronic Device Market is the leadless pacemaker sub-market, where Medtronic Micra and Boston Scientific enable compete for the growing leadless PM adoption replacing conventional transvenous pacemakers. Extravascular ICD creates a structural heart device innovation opportunity as Abbott EV-ICD expands the addressable ICD market. CRT-D creates a recurring high-value opportunity as heart failure device therapy maintains premium pricing for biventricular resynchronisation. Asia Pacific CIED creates geographic expansion as Japanese, Chinese, and Indian cardiac rhythm management programme investment grows.
5. Top Companies in the Cardiac Implantable Electronic Device Market
The following organisations hold leading positions in the Cardiac Implantable Electronic Device Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Medtronic (Micra, Evoque)
- Boston Scientific (EMPOWER, RESONATE)
- Abbott (EV-ICD, Gallant)
- BIOTRONIK (Edora, Ilesto)
- MicroPort (CRM)
- Oscor
- Oscor
- LivaNova
- Spectranetics (Philips)
- Zoll Medical
6. Market Segmentation
The Cardiac Implantable Electronic Device Market is analysed across 4 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Device | Pacemaker ICD CRT-D S-ICD Leadless PM EV-ICD |
| By Indication | Bradycardia VT/VF Prevention HF CRT Syncope |
| By Lead | Transvenous Lead Leadless Subcutaneous |
| By Geography | North America Europe Asia Pacific Latin America Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Cardiac Implantable Electronic Device Market trajectory over the forecast period:
Medtronic Micra AV Leadless Pacemaker Achieves 200,000 Cumulative Implants Demonstrating Leadless PM Scale.Medtronic Micra AV achieving 200,000 cumulative implants in 2024 demonstrates leadless pacemaker at commercial scale beyond early-adopter cardiology centres. Micra AV dual-chamber sensing achieving equivalent pacing therapy to transvenous dual-chamber pacemaker while eliminating lead-related complications demonstrates the clinical rationale for leadless PM adoption.
Boston Scientific enable Leadless Pacemaker Achieves FDA Approval Entering Leadless PM Competition.Boston Scientific EV-ICD achieving FDA approval in June 2023 demonstrates competitive entry into leadless pacemaker market. The 6-month primary endpoint with 97 percent pacing success validates the second-generation leadless PM platform at commercial safety standards.
Abbott Extravascular ICD Receives FDA Approval as advanced Shock Therapy Without Transvenous Lead.Abbott EV-ICD achieving FDA approval in June 2022 and growing commercial adoption through 2024 demonstrates extravascular ICD as a third category beyond transvenous and subcutaneous ICD. EV-ICD achieving similar shock efficacy to transvenous ICD while avoiding venous lead placement demonstrates the clinical rationale for cardiac shock therapy without vascular access.
For related market intelligence, see the Transcatheter Mitral Valve Repair Market.
8. Segmental Analysis
By device, the ICD and CRT-D segment dominated the Cardiac Implantable Electronic Device Market in 2025. Representing the largest revenue category as high-value defibrillator and resynchronisation devices generate premium per-device revenue. The Leadless Pacemaker segment is the fastest-growing category, advancing as Micra AV and enable convert conventional transvenous pacemaker volume.
By lead, the Leadless and Extravascular segment is registering the highest growth rate.
By indication, the Bradycardia segment dominated the Cardiac Implantable Electronic Device Market in 2025, as traditional single- and dual-chamber pacemaker implantation for sick sinus syndrome and AV block generates the highest device implant volume. HF CRT-D is the fastest-growing indication category, driven by expanding cardiac resynchronisation therapy eligibility criteria and growing heart failure population requiring biventricular pacing with defibrillation backup.
9. Regional Analysis
Regional demand patterns across the Cardiac Implantable Electronic Device Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America accounted for the largest share of the Cardiac Implantable Electronic Device Market in 2025, holding 46.5% of the global market. Electrophysiology centres, cardiac implant programmes, and cardiac device manufacturers are deploying pacemakers, ICDs, CRT devices, and subcutaneous ICD systems to manage cardiac rhythm disorders across large patient populations. FDA cardiac implantable device approvals and CMS reimbursement frameworks for device implantation, remote monitoring, and follow-up care are encouraging cardiac programmes to invest in CIED implantation capabilities. High heart failure and arrhythmia prevalence, established cardiac device implant infrastructure, and strong electrophysiology expertise are generating strong regional CIED demand.
Highest CAGR Region
Europe is expected to register the highest CAGR of 10.63% during the forecast period. Electrophysiology programmes, cardiac surgery centres, and cardiac device companies across Germany, France, the United Kingdom, Italy, and the Netherlands are expanding CIED implantation volumes as patient populations age and cardiac rhythm disorder diagnosis increases. European Heart Rhythm Association clinical guidelines and growing electrophysiology specialist training are expanding the physician base qualified to implant and manage cardiac devices. Rising atrial fibrillation prevalence, increasing heart failure diagnosis, and growing subcutaneous ICD adoption are generating European CIED demand.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology adoption trends and innovation tracking
- • Custom company profiling and benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country Trade Analysis
- • Country-level opportunity mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • List of Raw Material Suppliers
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Cardiac Implantable Electronic Device Market was valued at USD 22.41 Bn in 2025 and is projected to reach USD 44.42 Bn by 2034, growing at a CAGR of 7.9% over the 2026–2034 forecast period.
The Cardiac Implantable Electronic Device Market is projected to grow at a CAGR of 7.9% from 2026 to 2034.
North America accounted for the largest share of the Cardiac Implantable Electronic Device Market in 2025, holding 46.5% of the global market.
The leading companies in the Cardiac Implantable Electronic Device Market include Medtronic (Micra, Evoque), Boston Scientific (EMPOWER, RESONATE), Abbott (EV-ICD, Gallant), BIOTRONIK (Edora, Ilesto), MicroPort (CRM), Oscor, Oscor, LivaNova, Spectranetics (Philips), Zoll Medical.
Medtronic micra av leadless pacemaker achieves 200,000 cumulative implants demonstrating leadless pm scale.
By device, the ICD and CRT-D segment dominated the Cardiac Implantable Electronic Device Market in 2025.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.